T. Sakaki, R. Ando / Tetrahedron Letters 48 (2007) 7011–7014
7013
H
BocHN
2 eq
TMEDA
n
-BuLi
O
O
13
CeCl3
THF
O
8
BocHN
THF
THF
OH
y. 79%
14
1 eq
TMEDA
n
-BuLi
CeCl3
THF
13
1b
14
THF
THF
y. 7 2%
Scheme 5. Synthesis of the key intermediate 14.
5. The falcipain inhibitor as an anti-malarial agent: Li, X.;
Chen, H.; Jeong, J.; Chishti, A. H. Mol. Biochem.
Parasitol. 2007, 155, 26.
6. Kogen, H.; Kiho, T.; Tago, K.; Miyamoto, S.; Fujioka,
T.; Otsuka, N.; Suzuki-Konagai, K.; Ogita, T. J. Am.
Chem. Soc. 2000, 122, 1842.
tive 9 with 2 equiv of n-BuLi also afforded cycloprope-
none acetal 1b in 80% yield. However, all attempts to
generate lithiated cyclopropenone acetal 2a from acetal
11 were unsuccessful (Scheme 4).
We applied this reaction to the practical synthesis of cys-
teine proteinase inhibitors. After generating lithiated
cyclopropenone acetal 2b, a THF suspension of anhydr-
ous cerium chloride, which was prepared by dehydration
of CeCl3Æ7H2O,14 was added at À78 °C. (S)-Boc-Valinal
13 was then added, and the resulting mixture was stirred
for 3.5 h at that temperature. Work-up and purification
by column chromatography afforded the key intermedi-
ate 14 whose isolated yield was 79%.15 This yield was
better than the one by the previous method (72%) in
which thermally unstable cyclopropenone acetal 1b
was used as the starting compound4b (Scheme 5).
7. Thermal stability of compounds was evaluated by a Seiko
DSC-20 instrument. For each compound, a 1 mg of
sample was placed in a sealed Ag pressure-resistant cell
under nitrogen. The sample was then heated from room
temperature to 450 °C at a rate of 10 °C/min.
8. Ando, R.; Sakaki, T.; Jikihara, T. J. Org. Chem. 2001, 66,
3617.
9. 2-tert-Butoxy-3-phenylcyclopropanone
2,2-dimethyl-1,3-
propanediyl acetal 8. To a solution of 2-bromomethyl-2-
(chlorophenylmethyl)-5,5-dimethyl-1,3-dioxane 78 (185.1 g)
in THF (750 mL), t-BuOK (155.4 g) was added slowly
at 0 °C. The resulting solution was then stirred overnight
at room temperature, and THF (about 350 mL) was
removed in vacuo. After addition of water to the residue,
the water layer was extracted with n-heptane three times.
Combined extracts were washed with saturated NaCl
solution and dried over anhydrous sodium sulfate. After
filtration of the drying agent, the filtrate was evaporated
to give crude solids (164.1 g), which was dissolved in
2-propanol (300 mL) by heating. After this resulting
solution was cooled to 0 °C, water (350 mL) was added
slowly. The precipitates formed were filtered and washed
with 2-propanol–water mixture (1:1) to afford the desired
compound (147.8 g, 92%). Spectroscopic properties were
identical with reported ones.8
In conclusion, 2-tert-butoxy-3-phenylcyclopropanone
acetal 8 was found to be a stable precursor of lithiated
cyclopropenone acetal 2b. Acetal 8 was used in the prac-
tical synthesis of cysteine proteinase inhibitors; isolated
yield of the key intermediate 14 was better than the one
by the previous method.
Acknowledgment
10. No reactions proceeded in THF.
11. Baucom, K. B.; Butler, G. B. J. Org. Chem. 1972, 37,
1730.
The authors wish to thank Professor Eiichi Nakamura,
The University of Tokyo, for helpful discussions.
12. No reaction proceeded by treatment with triethylamine or
DBU.
References and notes
13. 2-Phenylcyclopropenone 2,2-dimethyl-1,3-propanediyl acet-
al 1b. To a solution of acetal 8 (1.00 g) in THF (10 mL),
TMEDA (1.03 mL) was added at À60 °C. n-BuLi
(1.61 mol/L solution in n-hexane, 4.29 mL) was then
added at À60 °C in 5 min, and the resulting solution was
stirred at that temperature for 2 h. After 4:1 mixture of
THF–water (3 mL) was added at À60 °C, the reaction
mixture was warmed to room temperature, and anhydrous
Na2SO4 was added. Subsequently, solids in this solution
were filtered by Celite, and the filtrate was evaporated to
give the crude mixture (894 mg). Purification by column
chromatography (n-hexane/AcOEt = 20/1) afforded the
desired compound (579 mg, 78%). Spectroscopic proper-
ties were identical with reported ones.8
1. (a) Isaka, M.; Matsuzawa, S.; Yamago, S.; Ejiri, S.;
Miyachi, Y.; Nakamura, E. J. Org. Chem. 1989, 54, 4727;
(b) Isaka, M.; Ejiri, S.; Nakamura, E. Tetrahedron 1992,
48, 2045.
2. Tokuyama, H.; Isaka, M.; Nakamura, E. Synth. Commun.
1995, 25, 2005.
3. Tokuyama, H.; Isaka, M.; Nakamura, E.; Ando, R.;
Morinaka, Y. J. Antibiot. 1992, 45, 1148.
4. (a) Ando, R.; Morinaka, Y.; Tokuyama, H.; Isaka, M.;
Nakamura, E. J. Am. Chem. Soc. 1993, 115, 1515; (b)
Ando, R.; Sakaki, T.; Morinaka, Y.; Takahashi, C.;
Tamao, Y.; Yoshii, N.; Katayama, S.; Saito, K.; Toku-
yama, H.; Isaka, M.; Nakamura, E. Bioorg. Med. Chem.
1999, 7, 571.
14. Imamoto, T.; Sugiura, Y.; Takiyama, N. Tetrahedron Lett.
1984, 25, 4233.